跳至主要内容
临床试验/NCT03700775
NCT03700775已完成不适用

Remote Hypertension Management Using Home Blood Pressure Telemonitoring and a Standardized Treatment Protocol

University of Mississippi Medical Center1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2018年9月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Adverse events

研究概览

简要总结

This is a prospective study evaluating the feasibility and safety of remote hypertension management using a central telemonitoring program among patients with elevated blood pressure (BP) at the University of Mississippi Medical Center (UMMC).

详细描述

Patients with elevated BP, identified by the electronic medical record, will be recruited for study enrollment. Patients will be mailed a telemonitoring kit including an electronic tablet equipped with a wireless BP cuff that transmits measurements directly to the UMMC electronic medical record and monitored by the UMMC Center for Telehealth. Patients will participate in a 6 month intervention period during which they will transmit daily BP recordings with regular contact by a Telehealth nurse coordinator who will provide education and encourage healthy lifestyle habits. Every 2 weeks BP medications will be adjusted according to an evidence-based treatment algorithm managed by the Center for Telehealth pharmacist using a standardized physician-approved protocol. Data analysis will track metrics of study enrollment, study completion, safety, therapeutic intensification, and BP change from baseline.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Age greater than 18 years
  • •Patient of UMMC clinician approving the study
  • •At least 2 clinic encounters in the past 12 months with systolic BP ≥ 140 mmHg and/or diastolic BP ≥ 90 mmHg

排除标准

  • •Stage 4 or 5 chronic kidney disease
  • •Systolic heart failure (LVEF <50%) or major cardiovascular event (MI, stroke) within 3 months
  • •Resistant hypertension (prescribed 3 or more antihypertensive medications at target doses) or known secondary cause of hypertension
  • •Pregnancy or inability/unwillingness to use birth control for women of child-bearing potential
  • •Institutionalized, dementia, limited life expectancy, uncontrolled mental illness, substance abuse, or other conditions that would prohibit ability to perform regular home BP monitoring

研究组 & 干预措施

Telemonitoring intervention

Experimental

干预措施: Remote Telemonitoring (Other)

结局指标

主要结局

Adverse events

时间窗: 6 months

Adverse event data will primarily be collected through self-report during each nursing coordinator contact with the patient. Participants will report any hospitalization longer than 12 hours, emergency room visits, or some-day clinic visits and reasons for those visits since the prior nurse coordinator encounter. Study staff will obtain and review medical records related to all adverse events including: deaths, hospitalizations, major cardiac events, incident kidney failure, and urgent evaluations for hypertension, hypotension, loss of consciousness or fainting, allergic reactions, hives, and angioedema. These events are evaluated for severity, expectedness, and potential relatedness to the intervention and study participation.

次要结局

  • Antihypertensive medication adjustments(6 months)
  • BP control rates(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Hypertension Management Using Telemonitoring | 临床试验